Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01956227 · ClinicalTrials.gov registry record · Phase 1
Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior
A Phase 1 study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
NCT01956227: Completed Phase 1 study, sponsored by University of Illinois at Urbana-Champaign.
NCT01956227 is a Phase 1 study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 37 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01956227, a Phase 1 study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
Falls are a serious health concern for persons with multiple sclerosis (MS). Over 50% of persons with MS suffer a fall over a 6-month periodwith the majority of falls resulting in medical attention for injuries (i.e., lacerations, bone fractures, \& head injuries). The effects of a fall are often compounded as it can lead to activity curtailment, physiological deconditioning, and institutionalization. Despite the importance of falls in persons with MS, the appropriate prevention strategies (i.e. rehabilitation approaches) are not clear. The purpose of this investigation is to determine whether exercise based or educational based interventions are more suited for fall prevention in older adults with MS.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Home-based exercise
- BEHAVIORAL Exercise plus Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
What the finished NCT01956227 record still lists
NCT01956227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 3 interventions - of which Education is the first listed.
NCT01956227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01956227 about?
NCT01956227 is a clinical study titled "Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior". Falls are a serious health concern for persons with multiple sclerosis (MS). Over 50% of persons with MS suffer a fall over a 6-month periodwith the majority of falls resulting in medical attention for injuries (i.e., lacerations, bone fractures, \& head injuries). The effects of a fall are often co...
What is the current status of trial NCT01956227?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2013-04. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01956227?
The interventions under investigation include: Education (BEHAVIORAL), Home-based exercise (BEHAVIORAL), Exercise plus Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01956227?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01956227's enrollment target sits among peer trials
37 1204th of 2000 higher than 791 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia